TheraRadar
← Back
Data updated: Mar 29, 2026

SHREE HARI INTL

NeurologyImmunology
Generics

SHREE HARI INTL is a generic drug manufacturer focused on Neurology, Immunology.

1985
Since
4
Drugs
-
Trials
62
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

BETAMETHASONE DIPROPIONATE 2026-01-26
AMANTADINE HYDROCHLORIDE 2025-12-05
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 50%
1 drugs
Immunology 50%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

AbbVie big-pharma
Immunology, Neurology
GSK big-pharma
Immunology, Neurology
Eli Lilly big-pharma
Immunology, Neurology
Roche big-pharma
Neurology, Immunology
Bristol-Myers Squibb big-pharma
Immunology, Neurology